Totally agree. Would add that this time vs last ti

Totally agree. Would add that this time vs last time is apples to oranges.(m/m vs s/c). If I'm a doc or facility that has already felt compelled to participate in the trial & has any inkling that the drug has saved lives, getting everything submitted would be something I would lose sleep over. M/M-maybe not so much. CYDY team seems to have a far better handle now. With that & recent hires, I look for CYDY to take much more initiative this time vs waiting on FDA guidance. Much misinformation all the way around early on. Now all parties have a much better perspective. Way fewer players in late stage clinical trials.(If not CYDY, what & when?) Familiarity & credibility(Far into the process & neither has given up on the other). FDA has been firm mostly( that's been discussed enough) & I don't anticipate them skipping many steps now, but feel like there will be far fewer reservations.Will add that I have been blown away by how informative & educational debates on this board have been of late ,while waiting on news. You guys rock! GLTA.